Eqis Capital Management Inc. Has $2.62 Million Holdings in Humana Inc. (HUM)

Eqis Capital Management Inc. raised its position in shares of Humana Inc. (NYSE:HUM) by 13.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,747 shares of the insurance provider’s stock after purchasing an additional 1,295 shares during the quarter. Eqis Capital Management Inc.’s holdings in Humana were worth $2,618,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HUM. WFG Advisors LP grew its stake in shares of Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares during the period. Acrospire Investment Management LLC bought a new stake in shares of Humana in the second quarter worth approximately $120,000. Independent Portfolio Consultants Inc. grew its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after acquiring an additional 94 shares during the period. Point72 Asia Hong Kong Ltd bought a new stake in shares of Humana in the first quarter worth approximately $128,000. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after acquiring an additional 325 shares during the period. Institutional investors and hedge funds own 95.11% of the company’s stock.

Humana Inc. (NYSE HUM) traded up 1.42% during trading on Wednesday, hitting $243.85. 463,534 shares of the stock traded hands. Humana Inc. has a 52-week low of $165.03 and a 52-week high of $259.76. The stock has a market cap of $35.24 billion, a P/E ratio of 20.06 and a beta of 0.86. The stock has a 50 day moving average price of $247.41 and a 200-day moving average price of $235.83.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter last year, the company earned $2.30 EPS. On average, analysts anticipate that Humana Inc. will post $11.56 EPS for the current fiscal year.

The business also recently declared a dividend, which was paid on Monday, October 16th. Investors of record on Friday, September 29th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

HUM has been the subject of a number of research analyst reports. Bank of America Corporation lifted their price target on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, July 14th. Cowen and Company reiterated a “buy” rating and issued a $230.00 price target on shares of Humana in a research note on Friday, July 14th. Piper Jaffray Companies reiterated a “buy” rating and issued a $246.00 price target on shares of Humana in a research note on Friday, July 14th. Citigroup Inc. initiated coverage on shares of Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 price target for the company. Finally, BidaskClub upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Twelve research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $253.90.

ILLEGAL ACTIVITY NOTICE: This piece was first published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://transcriptdaily.com/2017/10/18/eqis-capital-management-inc-has-2-62-million-holdings-in-humana-inc-hum.html.

In related news, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction on Friday, September 1st. The shares were sold at an average price of $258.14, for a total value of $2,014,266.42. Following the sale, the vice president now owns 8,831 shares of the company’s stock, valued at approximately $2,279,634.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of Humana stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the completion of the sale, the insider now directly owns 7,681 shares in the company, valued at approximately $1,927,777.38. The disclosure for this sale can be found here. Insiders sold a total of 55,595 shares of company stock worth $14,133,706 in the last three months. 0.80% of the stock is owned by corporate insiders.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply